Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities

Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. Currently, the standard treatment of glioblastoma includes surgery, radiotherapy, and chemotherapy. Despite aggressive treatment, the median survival is only 15 months. GBM progression and therapeutic resistance are t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guoqing, Zhong, Kunhong, Wang, Zeng, Zhang, Zongliang, Tang, Xin, Tong, Aiping, Zhou, Liangxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363573/
https://www.ncbi.nlm.nih.gov/pubmed/35967394
http://dx.doi.org/10.3389/fimmu.2022.964898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363573/
https://www.ncbi.nlm.nih.gov/pubmed/35967394
http://dx.doi.org/10.3389/fimmu.2022.964898

Ejemplares similares